kids cough (Natures Investment Holdings Pty Ltd dba Maxrelief USA)
Welcome to the PulseAid listing for the kids cough drug offered from Natures Investment Holdings Pty Ltd dba Maxrelief USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Natures Investment Holdings Pty Ltd dba Maxrelief USA |
| NON-PROPRIETARY NAME: | Drosera 30C, Spongia 30C, Kali Carbonicum 30C, Phospherous 30C, Ipeacacuhuana 30C, Pulsatilla 30C, Belladonna 30C |
| SUBSTANCE NAME: | DROSERA INTERMEDIA; SPONGIA OFFICINALIS WHOLE; POTASSIUM CARBONATE; PHOSPHORUS; PULSATILLA VULGARIS; ATROPA BELLADONNA; IPECAC |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LOZENGE |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2014-02-12 |
| END MARKETING DATE: | 0000-00-00 |
kids cough HUMAN OTC DRUG Details:
| Item Description | kids cough from Natures Investment Holdings Pty Ltd dba Maxrelief USA |
| LABELER NAME: | Natures Investment Holdings Pty Ltd dba Maxrelief USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30; 30; 30; 30; 30; 30; 30([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1) |
| START MARKETING DATE: | 2014-02-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76509-150_289aaee7-1d88-4140-aa3a-90ce1ee74e28 |
| PRODUCT NDC: | 76509-150 |
| APPLICATION NUMBER: | |
Other DROSERA INTERMEDIA; SPONGIA OFFICINALIS WHOLE; POTASSIUM CARBONATE; PHOSPHORUS; PULSATILLA VULGARIS; ATROPA BELLADONNA; IPECAC Pharmaceutical Manufacturers / Labelers:
